Strontium Ranelate: Dosing methodology [Design Issues]

posted by Srinetram – India, 2013-07-02 08:30 (4743 d 22:13 ago) – Posting: # 10908
Views: 4,079

Dear All

Good Morning (As per Indian Standard Time).

We are in process of conducting a fasting BE study for Strontium Ranelate Granules 2gm for EU submission.
As per the posology

The granules in the sachets must be taken as a suspension in a glass containing a minimum of 30 ml (approximately one third of a standard glass) of water.

My CRO has use the same words as mentioned in the SPC but while doing dispersion test we realized that after dispersing only 92-96% drug is getting transferred from the glass (some 4-8% drug/granules get stuck to the glass).

My worry is that if we will not hormonized the process (my plan was by rinsing the glass where the granules has been dispersed with some extra water ~150 ml and administring it to the volunteers) it may lead to inconculsive results.

How exactly such situation should be dealt with?
  1. Shall we follow the exact posology by dispersing the drug in 30 ml and administring it without giving any water
  2. or Shall we follow the follwoing process dispersive the drug in 30 ml water → Administer it to volunteer → rinse the glass with 150 ml of water → administer the rinsed water to the volunteer
  3. My next question will be How does EMEA prefere to do BE study for Suspensions? With water or without water?

:confused:

Regards
Srinetram

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
379 visitors (0 registered, 379 guests [including 37 identified bots]).
Forum time: 06:43 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5